About Index Trending news
Analyze
Pricing
Allurion

Allurion

Work at Allurion? Add yourself to this profile

Allurion

Developers of the Elipse™: the world's first procedureless gastric balloon for weight loss.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$27,000,000
Romulus Capital, IDO Investments, Cogepa Investments, +1
Venture capital
$19,020,000
Employees

Unknown size

Locations
HQ
Headquarters
$27,000,000 Venture capital (Series C)
TechCrunch , Xconomy , MedCity News , +1

Gastric bypass surgery in a pill startup Allurion gets $27 million as it pursues FDA approval

Health Funding
$19,020,000 Venture capital
MassDevice , sec

Weight loss balloon-maker Allurion raises $19m

Xconomy

Expanding in Stomachs and in Europe, Allurion Adds $6M

Health
$6,000,000 Venture capital
TechCrunch , BostInno

Allurion offers gastric bypass surgery in a pill

Health